###### Strengths and limitations of this study

-   There have been few studies examining the utility of comorbidity indices as predictors of mortality in patients admitted to the intensive care unit.

-   This study uses a large multi-institution cohort of critically ill patients admitted to several different intensive care units.

-   The results may not be generalisable to other institutions where coding practices may differ.

-   There is a chance of misclassification of vital status; however, there is no reason to suspect that this was differential between the two indices studied.

Introduction {#s1}
============

Utilisation of critical care resources has continued to escalate over the past several years, despite attempts to reduce healthcare expenditures.[@R1] [@R2] The availability of reliable outcome predictors of critically ill patients may help improve the value of care. Providing information on expected mortality may help patients and relatives make informed decisions about their goals of care. In addition, comorbidity indices have become an important tool for policymakers, administrators and researchers to predict population-based outcomes.[@R3]

In the general population, two of the most commonly used indices are the Deyo-Charlson Comorbidity Index[@R4] (DCCI) and the Elixhauser-van Walraven Comorbidity Index[@R5] (EVCI). Originally proposed by Charlson *et al*[@R6] in 1987, and then modified in 1992, the DCCI assigns a score to various chronic medical conditions and uses the sum to predict long-term mortality. Similarly, the EVCI score is based on 30 acute and chronic comorbidities to predict in-hospital mortality.[@R7] In 2009, the Elixhauser score was modified by van Walraven *et al*[@R5] into a weighted point system for streamlined use.

In contrast to scoring modalities such as the Acute Physiology and Chronic Health Evaluation (APACHE) and Sequential Organ Failure Assessment (SOFA), the DCCI and EVCI can be calculated at the time of intensive care unit (ICU) admission and do not require the interpretation of laboratory and bedside clinical data. Thus, they can be easily derived from administrative databases and their use in the critical care literature has been increasing. Both the DCCI and EVCI have been widely used to predict survival in acute hospital settings.[@R8] There have been several studies demonstrating the validity of these indices to predict in-hospital mortality in ICU patients.[@R12] Recent evidence suggests that the EVCI may be modestly superior to the DCCI for predicting mortality in hospitalised patients.[@R17] However to date, there are few to no studies comparing DCCI to EVCI for use in critically ill patients when examining long-term mortality across a variety of types of ICUs. Our primary objective was to evaluate and compare the DCCI to EVCI for predicting mortality at 30, 60, 180, 365 days. Our secondary objectives were to: (1) compare DCCI and EVCI across medical and surgical ICU settings; (2) determine if adding three readily available patient characteristics (age, race and sex) to the DCCI and EVCI would improve prediction of mortality; and (3) to calculate the number of patients who would be reclassified based on predetermined mortality risk levels depending on which index was used.

Methods {#s2}
=======

Setting {#s2a}
-------

We performed an observational study of ICU patients from two teaching hospitals in Boston, Massachusetts---Massachusetts General Hospital and Brigham and Women\'s Hospital. Massachusetts General Hospital is a 1052-bed hospital with burn, cardiac surgery, coronary, medical, neonatal, neuroscience, paediatric and surgical ICUs. Brigham and Women\'s Hospital is a 793-bed hospital with burn, cardiothoracic, coronary, medical, neonatal, neuroscience and surgical ICUs.

Data source and study population {#s2b}
--------------------------------

We performed an electronic chart review of all admissions to the ICUs at the two study centres. We included patients 18 years and older, admitted to any adult ICU from 1 January 2007 to 3 December 2012. In-hospital mortality data were captured via the medical record and mortality after discharge was obtained using the Social Security Administration\'s Death Master File. We excluded foreign nationals since they did not have social security numbers, and therefore mortality could not be verified in the Social Security Administration\'s Death Master File. For patients with multiple admissions to the ICU over the study time period, only the first admission to the ICU during the study time period was included in the analysis. Patients under the age of 18 were excluded (n=1206), as were patients with coding errors that prevented the calculation of either index (n=162).

Data collection and processing {#s2c}
------------------------------

We abstracted demographic and pertinent clinical information on all patients who met inclusion/exclusion criteria using a system-wide (including both hospitals) longitudinal patient data registry. Specific elements included were: (1) age; (2) sex; (3) race; (4) ICU type; (5) International Classification of Disease Clinical Modification 9 (ICD-9) discharge diagnosis codes; (6) hospital admission and discharge dates; (7) ICU admission and discharge dates; and (8) date of death.

The EVCI and DCCI were calculated using ICD-9 codes based on published algorithms.[@R21] Race and ethnicities were coded into Caucasian, African-American, Hispanic, Asian and Unknown/Other based on self-reported data. Age was treated as a continuous variable, and a sensitivity analysis was performed to ensure that there was no difference in model discrimination when age was included as 10-year categories. Time to death was calculated from the ICU admission date.

Statistical analysis {#s2d}
--------------------

For both the DCCI and EVCI, receiver operator characteristic (ROC) curves were constructed to generate the areas under the curve (AUCs) for predicting 30, 60, 90, 180, and 365-day mortality following ICU admission. To test differences in the discriminative ability of the indices, the AUCs were compared using a previously described non-parametric approach.[@R22] This analysis was repeated for each type of ICU. For the primary analysis, each index was compared with the other both as the sole predictor as well as with age, sex and race included in the model. These factors were selected since they are typically easily available in administrative databases.

Given that the implications of differences in AUCs can be difficult to interpret, we set to calculate how many patients would undergo reclassification of mortality risk depending on which index score was used. The probability of mortality for an individual patient was calculated using a logistic regression model with DCCI as the sole independent covariate. Patients were then placed into predefined categories of predicted risk of mortality (0--4.9%, 5--9.9%, 10--14.9% and ≥15%). The patients were then reclassified into a higher, equal or lower risk classification based on their EVCI score as calculated from a separate logistic regression. The net reclassification improvement was calculated to determine whether this reclassification was appropriate.[@R23]

We also performed several additional analyses after the results of the above described analysis were obtained. To further understand the calibration of the models, calibration plots were created for each index with 1-year mortality as the outcome. We also constructed time-dependent ROC curves by modelling our data as a survival data set and assessed the AUC at the same time points as the primary analysis. Finally, we examined the discriminatory ability of the indices to predict prolonged length of stay in both the ICU and the hospital. These were defined as having a length of stay greater than the 75th centile, which was 5 days for the ICU and 16 days for the hospital.

The creation of the ROC curves and their analyses was performed in STATA V.12 (StataCorp, College Station, Texas, USA). The remainder of the analysis was performed in R V.3.2.0 (R Foundation for Statistical Computing, Vienna, Austria). Specifically the reclassification analysis and the calibration plots were created using the PredictABEL package, and the time-dependent ROC curves were constructed using the timeROC package. All tests were performed with a two-tailed statistical level of significance set at p\<0.05.

Results {#s3}
=======

Between January 2007 and December 2012, a total of 59 816 individual patients from 12 ICUs at two study hospitals met our study criteria ([table 1](#BMJOPEN2015008990TB1){ref-type="table"}). ICUs with the highest percentage of admissions included the cardiothoracic surgical ICU (23%), coronary care units, neurological/neurosurgical ICU (22%), medical ICU (19%) and surgical ICU (18%). Patients had a mean age of 64 (SD 16) and 81% of the population was Caucasian. The average DCCI score was 7 (SD 4) and the average EVCI was 16 (SD 12). Overall mortality at 30, 90, 180 and 365 days was 11%, 16%, 20% and 24%, respectively. The specific frequency of each comorbidity used to calculate the respective indices is presented in [table 2](#BMJOPEN2015008990TB2){ref-type="table"}.

###### 

Demographic data

  ------------------------------ ----------------
  Age (years), mean (SD)         64.3 (±16.0)
  Race, n (%)                    
   White                         48 274 (80.7)
   Black                         3781 (6.3)
   Hispanic                      2475 (4.1)
   Asian                         1392 (2.3)
   Unknown/other                 3894 (6.5)
  Gender, n (%)                  
   Male                          34 132 (57.1)
   Female                        25 684 (42.9)
  Admission ICU, n (%)           
   Burn ICU                      3753 (6.3)
   CCU                           7756 (12.9)
   CTICU                         13 480 (22.5)
   MICU                          11 419 (19.0)
   NSICU                         12 864 (21.5)
   SICU                          10 704 (17.9)
  Mortality, n (%)               
   30 days                       6574 (11.0)
   90 days                       9651 (16.1)
   180 days                      11 960 (20.0)
   1 year                        14 551 (24.3)
  Comorbidity score, mean (SD)   
   Charlson                      7.22 (±3.81)
   Elixhauser                    16.28 (±11.55)
  ------------------------------ ----------------

CCU, coronary care unit; CTICU, cardiothoracic ICU; ICU, intensive care unit; MICU, medical ICU; NSICU, neuroscience ICU; SICU, surgical ICU.

###### 

Frequency of individual constituents of each comorbidity index

  Deyo-Charlson comorbidities              Frequency (%)   Elixhauser-van Walraven comorbidites        Frequency (%)
  ---------------------------------------- --------------- ------------------------------------------- ---------------
  AIDS                                     371 (0.6)       HIV/AIDS                                    369 (0.6)
  Any malignancy                           23 249 (38.9)   Alcohol abuse                               3361 (5.6)
  Cerebrovascular disease                  20 926 (35.0)   Blood loss/anaemia                          1167 (2.0)
  Chronic pulmonary disease                16 097 (26.9)   Cardiac arrhythmias                         38 084 (63.7)
  Congestive heart failure                 22 693 (37.9)   Chronic pulmonary disease                   15 877 (26.5)
  Dementia                                 1019 (1.7)      Coagulopathy                                13 187 (22.1)
  Diabetes with complications              3311 (5.5)      Congestive heart failure                    22 464 (37.6)
  Diabetes without chronic complications   17 063 (28.5)   Deficiency/anaemia                          13 336 (22.3)
  Hemiplegia or paraplegia                 4562 (7.6)      Depression                                  8231 (13.8)
  Metastatic solid tumour                  8627 (14.4)     Diabetes complicated                        4623 (7.7)
  Mild liver disease                       2307 (3.9)      Diabetes uncomplicated                      16 821 (28.1)
  Moderate/severe liver disease            1996 (3.3)      Drug abuse                                  2526 (4.2)
  Myocardial infarction                    18 123 (30.3)   Fluid and electrolyte disorders             30 627 (51.2)
  Peptic ulcer disease                     4037 (6.8)      Hypertension complicated                    265 (0.4)
  Peripheral vascular disease              9345 (15.6)     Hypertension uncomplicated                  33 857 (56.6)
  Renal disease                            13 077 (21.9)   Hypothyroidism                              6468 (10.8)
  Rheumatoid disease                       2230 (3.7)      Liver disease                               4631 (7.7)
                                                           Lymphoma                                    3319 (5.6)
                                                           Metastatic cancer                           8559 (14.3)
                                                           Neurodegenerative disorders                 0 (0)
                                                           Obesity                                     4285 (7.2)
                                                           Neurological disorders                      11 278 (18.9)
                                                           Paralysis                                   4824 (8.1)
                                                           Peptic ulcer disease (excluding bleeding)   1691 (2.8)
                                                           Peripheral vascular disease                 12 963 (21.7)
                                                           Psychoses                                   5942 (9.9)
                                                           Pulmonary circulation disorders             10 471 (17.5)
                                                           Renal failure                               12 605 (21.1)
                                                           Rheumatoid disorders                        2654 (4.4)
                                                           Solid tumour without metastasis             23 476 (39.3)
                                                           Valvular heart disease                      14 033 (23.5)
                                                           Weight loss                                 5857 (9.8)

Predictors of mortality {#s3a}
-----------------------

As a predictor of 30-day mortality, the AUC for the DCCI was 0.65 (95% CI 0.65 to 0.67) while AUC for the EVCI was 0.66 (95% CI 0.65 to 0.66), p=0.02. The AUCs increased as the time window for assessing mortality was lengthened. The AUC for 1-year mortality was 0.72 for both indices (AUC for DCCI 0.72 (95% CI 0.71 to 0.72) vs AUC for EVCI 0.72 (95% CI 0.72 to 0.72), p=0.46). Comparisons of AUCs for all study time points can be found in [table 3](#BMJOPEN2015008990TB3){ref-type="table"}.

###### 

Comparison of area under receiver operator characteristic curves for the Charlson and Elixhauser Comorbidity Indices as predictors of mortality at various time points

                      Charlson Comorbidity Index   Elixhauser Comorbidity Index   p Value
  ------------------- ---------------------------- ------------------------------ ---------
  30-day mortality    0.65 (0.65 to 0.66)          0.66 (0.65 to 0.67)            0.02
  90-day mortality    0.69 (0.68 to 0.70)          0.71 (0.70 to 0.71)            \<0.001
  180-day mortality   0.71 (0.70 to 0.71)          0.72 (0.71 to 0.72)            \<0.001
  365-day morality    0.72 (0.71 to 0.72)          0.72 (0.72 to 0.72)            0.46

Values represent area under the curve with 95% CIs in parentheses. p Values calculated by testing the difference between the areas under the curve using a t test.

Prediction by type of ICU {#s3b}
-------------------------

We compared the DDCI and EVCI within different subtypes of ICUs. Overall, the two indices predicted mortality similarly within each ICU type across different time periods. The exception to this was the neurosciences ICU where the DCCI was superior to the EVCI (1-year mortality AUC 0.73 (95% CI 0.72 to 0.74) vs 0.68 (95% CI 0.67 to 0.70), p=0.005). [Table 4](#BMJOPEN2015008990TB4){ref-type="table"} lists the AUCs for 30-day and 365-day mortality across ICU types.

###### 

Comparison of area under receiver operator characteristic curves for the Charlson and Elixhauser comorbidity indices as predictors of mortality for different intensive care units

              30-day mortality      1-year mortality                                                            
  ----------- --------------------- --------------------- --------- --------------------- --------------------- -------
  Burn ICU    0.62 (0.58 to 0.65)   0.63 (0.60 to 0.66)   0.11      0.73 (0.71 to 0.75)   0.73 (0.71 to 0.75)   0.57
  CCU         0.65 (0.64 to 0.67)   0.64 (0.63 to 0.66)   0.17      0.72 (0.71 to 0.73)   0.71 (0.69 to 0.72)   0.002
  CTICU       0.71 (0.69 to 0.73)   0.68 (0.66 to 0.70)   0.001     0.75 (0.74 to 0.77)   0.73 (0.72 to 0.75)   0.001
  MICU        0.65 (0.64 to 0.67)   0.64 (0.63 to 0.65)   0.03      0.71 (0.70 to 0.72)   0.70 (0.69 to 0.71)   0.005
  Neuro ICU   0.60 (0.58 to 0.61)   0.65 (0.63 to 0.66)   \<0.001   0.68 (0.67 to 0.70)   0.73 (0.72 to 0.74)   0.005
  SICU        0.68 (0.66 to 0.70)   0.66 (0.64 to 0.67)   0.001     0.73 (0.72 to 0.74)   0.72 (0.71 to 0.73)   0.050

Values represent area under the curve with 95% CIs in parentheses.

Addition of age, race, sex to the DCCI and EVCI {#s3c}
-----------------------------------------------

There was minimal improvement in discrimination when adding the comorbidity indices to basic demographic information (ie, age, race and sex) for both the DCCI and EVCI scores. The AUC for DCCI with demographic variables added was 0.67 (95% CI 0.66 to 0.67) for the prediction of 30-day mortality versus 0.65 (95% CI 0.65 to 0.66) for the index alone (p\<0.001). The AUC for the EVCI score with demographics included was 0.73 (95% CI 0.73 to 0.74) for 1-year mortality compared with 0.72 (95% CI 0.71 to 0.72) for EVCI alone (p\<0.001). [Table 5](#BMJOPEN2015008990TB5){ref-type="table"} lists the various combinations and compares the AUCs to a prediction model with just demographic information. All of the indices and combinations with demographic information performed better than demographic variables alone with all p\<0.001.

###### 

Areas under the curve for variation combinations of comorbidity indices and demographic data

                                C-statistic         p Value
  ----------------------------- ------------------- -----------
  30-day mortality                                  
   Age, race, sex               0.61 (0.60--0.62)   --
   Charlson only                0.65 (0.65--0.66)   Reference
   Charlson, age, race, sex     0.67 (0.66--0.67)   \<0.001
   Elixhauser only              0.66 (0.65--0.67)   Reference
   Elixhauser, age, race, sex   0.69 (0.68--0.70)   \<0.001
  90-day mortality                                  
   Age, race, sex               0.60 (0.59--0.60)   --
   Charlson only                0.69 (0.68--0.70)   Reference
   Charlson, age, race, sex     0.69 (0.69--0.70)   \<0.001
   Elixhauser only              0.71 (0.70--0.71)   Reference
   Elixhauser, age, race, sex   0.73 (0.72--0.73)   \<0.001
  180-day mortality                                 
   Age, race, sex               0.59 (0.59--0.60)   --
   Charlson only                0.71 (0.70--0.71)   Reference
   Charlson, age, race, sex     0.71 (0.71--0.72)   \<0.001
   Elixhauser only              0.72 (0.71--0.72)   Reference
   Elixhauser, age, race, sex   0.73 (0.73--0.74)   \<0.001
  365-day mortality                                 
   Age, race, sex               0.59 (0.58--0.59)   --
   Charlson only                0.72 (0.71--0.72)   Reference
   Charlson, age, race, sex     0.72 (0.72--0.73)   \<0.001
   Elixhauser only              0.72 (0.72--0.72)   Reference
   Elixhauser, age, race, sex   0.73 (0.73--0.74)   \<0.001

p Value for difference comparing the comorbidity index alone to a model with the respective comorbidity index plus age, race and sex included in the model.

Reclassification {#s3d}
----------------

The reclassification data highlight the differences between the DCCI and EVCI, showing the number of patients requiring reclassification when using a different index for predicting mortality (see [table 6](#BMJOPEN2015008990TB6){ref-type="table"}). When patients were divided into four categories of mortality likelihood, there were a total of 26 388 (44%) patients who required reclassification for their 30-day mortality risk. The net reclassification improvement for 30-day mortality risk was 7.5% (95% CI 6.8% to 9.1%) favouring the EVCI. This means that compared with individuals without the outcome, individuals with the outcome were 7.5% more likely to move up a risk category than down. When examining 1-year mortality risk, there were a total of 18 445 (31%) patients that required reclassification, with a net reclassification improvement of 4.4% (95% CI 3.5% to 5.2%).

###### 

Reclassification data based on predicted mortality

                                   Elixhauser predicted probability                                                 
  -------------------------------- ---------------------------------- --------------- ------------- --------------- ---------------
  *30-day mortality*                                                                                                
  Charlson predicted probability                                                                                    
   0--5%                           888 (15.3)                         1241 (4.7)      117 (0.7)     12 (0.1)        2258 (3.8)
   5--10%                          4678 (80.4)                        19 899 (75.2)   6301 (38.1)   1515 (13.8)     32 393 (54.2)
   10--15%                         159 (2.7)                          4348 (16.4)     5955 (36.0)   2772 (25.23)    13 234 (22.1)
   \>15%                           93 (1.6)                           981 (3.7)       4171 (25.2)   6686 (60.9)     11 931 (20.0)
   Total                           5818                               26 469          16 544        10 985          59 816
  *1-year mortality*                                                                                                
  Charlson predicted probability                                                                                    
   0--5%                           0                                  0               0             0               0
   5--10%                          33 (50.0)                          2332 (28.7)     1499 (14.6)   1322 (3.2)      5186 (8.7)
   10--15%                         25 (37.9)                          3257 (40.1)     3051 (29.7)   4053 (9.8)      10 386 (17.4)
   \>15%                           8 (12.1)                           2540 (31.3)     5708 (55.6)   35 988 (87.0)   44 244 (74.0)
   Total                           66                                 8129            10 258        41 363          59 816

Additional analyses {#s3e}
-------------------

As further sensitivity analysis, model calibration of the indices was assessed through the plotting of calibration plots with the outcome of 1-year mortality. The plots are displayed in [figure 1](#BMJOPEN2015008990F1){ref-type="fig"} and demonstrate adequate calibration. When analysing the data as a survival data set, the results of the calculated AUCs from the time-dependent ROC curves were similar to the primary analysis. The AUCs across time points are displayed in [figure 2](#BMJOPEN2015008990F2){ref-type="fig"}. When examining the ability of both indices to predict prolonged length of stay, the EVCI outperformed for the DCCI. For prolonged ICU stay, EVCI had an AUC of 0.64 (95% CI 0.63 to 0.64) versus the DCCI that had an AUC of 0.53 (95% CI 0.53 to 0.54) with a p value for difference of \<0.001. When examining the ability to predict a hospital stay of greater than 16 days, EVCI had an AUC of 0.67 (95% CI 0.67 to 0.68) versus the DCCI which had an AUC of 0.57 (95% CI 0.56 to 0.57) with a p value for difference of \<0.001.

![Calibration plots for Elixhauser-van Walraven Comorbidity Index and Deyo-Charlson Comorbidity Index for prediction of 1-year mortality after admission to the intensive care unit.](bmjopen2015008990f01){#BMJOPEN2015008990F1}

![Calculation of areas under the curve from time-dependent receiver operator characteristic curves for one-year mortality.](bmjopen2015008990f02){#BMJOPEN2015008990F2}

Discussion {#s4}
==========

In our large cohort of ICU admissions, we found that the DCCI or EVCI were similar at predicting mortality at various time intervals and that the predictive ability of both indices increased when examining long-term outcomes. These results were consistent across various types of ICUs, with the exception of the neurosciences ICU where the DCCI was found to be superior. Consistent with a previous study,[@R17] the indices performed better than demographic data alone. However, the addition of demographic data to both indices did not meaningfully affect the predictive utility of these indices.

Previous studies have shown that the EVCI, in general, appears to predict short-term and long-term mortality better than the DCCI for a variety of patients requiring acute hospitalisation.[@R18]

While the EVCI was statistically superior to the DCCI at predicting mortality at 30, 90 and 180 days, the difference was small and likely reached significance due to the large sample size of the study. When dividing the cohort into predicted risk categories, a large proportion of the population was reclassified into different categories depending on which index was used. However, the net reclassification index for 30-day mortality was only 7.5%. This suggests that while the EVCI may offer some advantage over the DCCI, the majority of this reclassification was not informative.

We did detect a difference between the two indices in the subgroup of patients admitted to the neurosciences ICU. While the reason for this observation is unclear, it may be due to the DCCI\'s heavy point allocation to metastatic solid tumours (6 points) and the additional points given to dementia (1 point) and cerebrovascular disease (1 point). The EVCI is less clear with regard to neurological diseases, allocating points to paralysis, 'other neurological disorders' and metastatic cancer.

Another interesting finding was that both indices improved mortality prediction over time. The AUC for the DCCI improved from 0.65 at 30 days to 0.72 at 365 days; and similarly, the AUC for EVCI improved from 0.66 at 30 days to 0.72 at 365 days. This improvement most likely is because as critically ill patients survive past their ICU stay, the major determinants of survival are related to their baseline comorbidities, age and new organ dysfunction as a result of their critical illness. Without prospective and organ dysfunction data, this is only a theory but two previous studies are congruent with our findings, where the researchers found that patients with higher organ dysfunction scores during their ICU stay had higher utilisation of healthcare resources and mortality up to 1 year, and possibly 5 years.[@R24] [@R25]

Our study examined the real-world need of risk prediction with large administrative and claims databases for ICU patients. While physiology-based severity scores may have better predictive capabilities for short-term and long-term mortality, they are difficult to calculate without extensive resources. Additionally, these measures may not be available in large, historical cohorts of critically ill patients. In this study, we were not able to compare the DCCI and EVCI to commonly used physiology-based severity of illness scores. However, a previous study found that the combined DCCI with administrative variables performed similarly to physiology-based measures.[@R14] Our results support this finding that a risk predictor based primarily on administrative data may be sufficient to serve as risk prediction tools in future studies, especially those examining long-term outcomes. Therefore, a lack of physiology-based severity scores does not preclude adequate risk adjustment of patients in studies of ICU patients using administrative databases. Given that both indices were similar in their discriminatory abilities, the DCCI may be more advantageous to use since it requires less data points to calculate it.

Our study has several limitations inherent to its design. First, calculation of these comorbidity indices is reliant on ICD-9 coding. This shortcoming was evident by the fact that none of the patients within our cohort had codes for a neurodegenerative disorder when calculating the EVCI. However, these coding discrepancies would likely be present when applying these metrics for non-research purposes, and thus the findings are representative of the 'real-world' accuracy of these indices. There is a risk of misclassification when assessing vital status; however, we have no reason to suspect that this risk was differential for either measure. Our cohort consisted of patients at two large academic hospitals, and thus the results may not be generalisable to other settings where coding practices may differ.

Conclusion {#s5}
==========

Our study found that the DCCI and EVCI were similar at predicting mortality in patients admitted to the ICU. Both indices demonstrated an improvement in discrimination as the time window of interest was lengthened. Given the policy, research and administrative implications of interpreting population data, selecting an accurate, yet practical comorbidity index for risk prediction is crucial. While a physiology-based comorbidity index is preferred for mortality risk assessment in ICU patients, our study suggests that either the DCCI or EVCI may be appropriate for predicting long-term mortality when physiology-based indices are not readily available. Further studies are needed to determine if the DCCI or EVCI can be used in place of physiology-based risk indices.
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